S.G. Power Limited has announced a strategic step into Pakistan’s healthcare sector by signing a distribution agreement with Lablink Enterprises for the distribution of Nipro hospital products across the country.
The agreement marks an important milestone in the company’s diversification strategy, as it seeks to expand its footprint beyond its existing business operations and strengthen its presence in the growing medical devices market.
Nipro Corporation, headquartered in Osaka, Japan, is one of the world’s leading healthcare and medical technology companies. With more than 70 years of experience, the company develops and manufactures a wide range of medical devices, pharmaceutical products, and pharmaceutical packaging solutions. Nipro operates in more than 150 countries and is widely recognized for its expertise in infusion therapy, vascular care, and other hospital products.
Under the agreement, S.G. Power will collaborate with Lablink Enterprises, the exclusive distributor of Nipro hospital products in Pakistan. Lablink has represented the Nipro brand in the local market for over 15 years, supplying leading hospitals, healthcare institutions, and clinical care providers across the country.
The company believes the partnership will leverage Nipro’s globally trusted product portfolio and Lablink’s established distribution network to strengthen its position in Pakistan’s healthcare industry. The collaboration is also expected to create new growth opportunities in the country’s expanding medical devices sector.
S.G. Power stated that the agreement forms part of its broader strategy to increase its presence in healthcare and build a sustainable platform for future expansion. The company added that it will keep shareholders informed of any significant developments in accordance with applicable regulatory requirements.
The move reflects S.G. Power’s commitment to exploring new business opportunities while contributing to improved access to high-quality medical products for healthcare providers across Pakistan.
